Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I

被引:49
|
作者
Thomas, Janet A. [1 ,2 ]
Beck, Michael [3 ]
Clarke, Joe T. R. [4 ]
Cox, Gerald F. [5 ,6 ,7 ]
机构
[1] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johannes Gutenberg Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany
[4] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[5] Genzyme Corp, Cambridge, MA USA
[6] Childrens Hosp Boston, Boston, MA USA
[7] Harvard Univ, Sch Med, Boston, MA USA
关键词
ENZYME-REPLACEMENT THERAPY;
D O I
10.1007/s10545-010-9113-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Scheie syndrome is the most attenuated and rarest form of mucopolysaccharidosis type I (MPS I), an inherited lysosomal storage disorder. Only small patient series have previously been reported. Using natural history data from the uniquely large population of 78 Scheie patients enrolled in the MPS I Registry, we characterized the onset and prevalence of clinical manifestations and explored reasons for delayed diagnosis of the disease. Median patient age was 17.5 years; 46% of the patients were male, and 88% were Caucasian. Of 25 MPS I-related clinical features, cardiac valve abnormalities, joint contractures, and corneal clouding were each reported by > 80% and all three by 53% of patients. Carpal tunnel syndrome, hernia, coarse facial features, and hepatomegaly were each reported by > 50% of patients. Age at onset of the clinical features varied widely between individuals, but the median age at onset was 3 years for hernia and between 5 and 12 years for most features, including coarse facial features, hepatomegaly, joint contractures, bone deformities, cardiac valve abnormalities, cognitive impairment, and corneal clouding. Carpal tunnel syndrome, cardiomyopathy, and myelopathy arose more commonly during adolescence or adulthood. Delays up to 47 years intervened between symptom onset and disease diagnosis, and the longest delays were associated with later age at symptom onset and symptom onset before 1980. In summary, Scheie syndrome usually emerges during childhood, and recognition of attenuated MPS I requires awareness of the multisystemic disease manifestations and their diverse presentation. Given the availability of etiologic treatment, prompt diagnosis is important.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 18 条
  • [1] The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
    David Moore
    Martin J Connock
    Ed Wraith
    Christine Lavery
    Orphanet Journal of Rare Diseases, 3
  • [2] A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
    Faller, Kiterie M. E.
    Ridyard, Alison E.
    Gutierrez-Quintana, Rodrigo
    Rupp, Angie
    Kun-Rodrigues, Celia
    Orme, Tatiana
    Tylee, Karen L.
    Church, Heather J.
    Guerreiro, Rita
    Bras, Jose
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2020, 34 (05) : 1813 - 1824
  • [3] Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
    Sugiura, Kenta
    Kubo, Toru
    Ochi, Yuri
    Baba, Yuichi
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kitaoka, Hiroaki
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 25
  • [4] Mucopolysaccharidosis I, Hurler syndrome: A case report
    Amorin, Milagros
    Carlin, Andrea
    Proetzel, Ana
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2012, 110 (05): : E103 - E106
  • [5] Dysmorphic syndrome due to mucopolysaccharidosis type I
    Mounach, J.
    Abilkassem, R.
    Satte, A.
    Ouahmane, Y.
    Berri, M. Ait
    Agadr, A.
    Ouhabi, H.
    Zerhouni, A.
    ARCHIVES DE PEDIATRIE, 2014, 21 (04): : 415 - 417
  • [6] Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
    Martins, Ana Maria
    Lindstrom, Kristin
    Kyosen, Sandra Obikawa
    Munoz-Rojas, Maria Veronica
    Thibault, Nathan
    Polgreen, Lynda E.
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [7] Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy
    Sato, Yohei
    Fujiwara, Masako
    Kobayashi, Hiroshi
    Yoshitake, Michio
    Hashimoto, Kazuhiro
    Oto, Yuji
    Ida, Hiroyuki
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 : 94 - 97
  • [8] Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry
    Polgreen, Lynda E.
    Bay, Luisa
    Clarke, Lorne A.
    Guffon, Nathalie
    Jones, Simon A.
    Muenzer, Joseph
    Flores, Ana Lorena
    Wilson, Kathryn
    Viskochil, David
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (10) : 2941 - 2951
  • [9] Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI
    Ahmed, Alia
    Shapiro, Elsa
    Rudser, Kyle
    Kunin-Batson, Alicia
    King, Kelly
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 7 : 27 - 31
  • [10] Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion
    Guffon, Nathalie
    Journeau, Pierre
    Brassier, Anais
    Leger, Juliane
    Chevallier, Bertrand
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (04) : 593 - 603